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Kardiale Vorsorgeuntersuchung bei
professionellen Handball Spielern –
Standortbestimmung im Rahmen der EHF
Handball Europameisterschaft 2010 in Österreich
Zusammenfassung. In vielen Sportarten wird ein regelmä-
ßiges, richtliniengetreues kardiales Screening zur Verhinderung
des plötzlichen Herztods noch immer nicht gewährleistet. Wir
nahmen die Handball Europameisterschaften, welche 2010 in
Wien undweiteren Städten inÖsterreich stattfanden, zumAnlass,
die aktuelle Situation bei Toplevel-Handballern zu untersuchen:
Ein standardisierter Fragebogen wurde vor dem Turnier an alle
qualiﬁzierten Teams und Spieler versandt. Eine Rücklaufrate von
42,7% kann zum Schluss führen, dass das Problem des plötz-
lichen Herztods bei den Spielern und Verantwortlichen
unterschätzt wird. Die überwiegende Mehrzahl der Spieler
(82%) wurde gemäß der Auswertung der Fragebögen korrekt,
entsprechend der aktuellen Screening-Richtlinien untersucht. In
gut der Hälfte der Teams wurde das Screening jedoch
inhomogen durchgeführt. 5 Spieler (4,1%) wurden zumindest
nicht innerhalb der letzten Jahre untersucht, bei 1 Spieler (0,8%)
wurde kein EKG durchgeführt. Während 69% der Handballer ihr
erstes Screening erst nach dem Alter von 18 Jahren durchliefen,
wurden 16 Spieler (13,1%) gar niemals zuvor einer kardialen
Vorsorgeuntersuchung unterzogen. Schließlich identiﬁzierten
wir aufgrund der Fragebögen 17 Athleten (13,9%) mit einer hoch
suspekten Anamnese, wovon 2 Athleten (1,6%) niemals zuvor
kardiologisch abgeklärt wurden.
Schlüsselwörter: Plötzlicher Herztod, kompetitiver Sport,
Handball, kardiales Screening
Summary. In many sports, regular cardiac screening for exer-
cise-associated sudden cardiac death is still not provided. To set
up the current situation in top-skilled handball players qualiﬁed
for the 2010 European Handball Championship in Austria, a
standardised questionnaire was sent to every team.
The fact that only 42.7% of the players returned the question-
naire may lead to the conclusion that the awareness of the
problem is quite low. However, 82% of these players have been
screened according to current recommendations. Half of the
teams were screened inhomogeneously: 5 players (4.1%) have
not been screened within the last years, 1 athlete (0.8%) was
screened without an ECG. While 69% of the athletes got their ﬁrst
screening only after the age of 18, 16 players (13.1%) never went
through a speciﬁc screening ever.
We identiﬁed 17 athletes (13.9%) with a highly suspicious
history, 2 of them (1.6%) never underwent a medical screening
at all.
Key words: Sudden cardiac death, competitive sports, hand-
ball, cardiac screening
Introduction
Although exercise-associated sudden cardiac
death (SCD) in young competitive athletes is overall
quite rare [1–5], these fatal events always represent an
incredible tragedy. However, most of these events
could be prevented by an adequate pre-competition
cardiac screening [6–8]. Although the large European
andAmerican cardiologic societies and the Internation-
al Olympic Committee (IOC) implemented their spe-
ciﬁc recommendations concerning prevention of
exercise-related sudden cardiac death [9–18], in many
sports associations and clubs, a regular cardiac
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screening is still not assured. This fact is alarming as
especially the long lasting Italian experience with large
cohorts of athletes impressively demonstrated that an
accurate regular and cost-effective cardiac screening
prevents more than 90% of exercise-related SCD in
young competitive athletes [7, 8].
This basic screening, regularly repeated every
single or second year (beginning at the age of 12 to
14) consists of three major factors: Firstly, an accurate
acquisition of the athletes history, including personal
as well as family history. The importance of the
athletes history may be outlined by the fact that most
of the underlying cardiac conditions leading to an
increased risk of SCD are inherited [1–5]. Secondly,
a focused physical examination of the athlete and
ﬁnally, a 12-lead resting ECG completes the basic
screening strategy. It is the use of the ECG (recom-
mended by the IOC, the European Society of Cardiol-
ogy (ESC) and important sports associations as the
Fédération International de Football [FIFA]), which
has mainly been shown to be responsible for the
dramatic decrease of SCD cases during the last dec-
ades [7, 8].
While associations like FIFA implemented and
developed updated and speciﬁc guidelines and try to
assure the feasibility of their pre-competition medical
screening (PCMA), the situation in other popular sports
is rather unknown.
The recent tragic death of a young German hand-
ball player in 2009 and this year´s EHF European
Handball Championship taking place in Austria were
our main incitements to highlight the current situation
concerning prevention of sudden cardiac death in
handball, one of the most popular sports in Europe
and increasingly worldwide.
The fact that handball is played by more than 30
million athletes all over the world (about 850 000
handball players in Germany) reinforces the need for
an adequate awareness concerning pre-competition
medical screening.
The aim of our study was to evaluate the current
situation in top skilled handball players, to judge the
current concept and to provide adaptions and conse-
quences that might also serve as a role model for other
sports.
Methods
In agreement with the European Handball Feder-
ation (EHF), a standardised questionnaire (provided in
different languages: English, German, Spanish and Ser-
bo-Croatian, respecting the origin of the different
teams) was sent to every team that qualiﬁed for the
2010 EHF European Handball Championship three
months prior to the tournament. The questionnaire
was generally based on the recommendations of the
International Olympic Committee and the ESC [9, 15]. It
was subdivided into two parts: The ﬁrst part of the
questionnaire gathered the personal and family history
based on the recommendations of the International
Olympic Committee and the ESC [15, 18]. The second
part evaluated whether the athletes ever got a pre-
competition medical screening before and if so, what
this screening included and if it was repeated regularly
(e.g. medical history, physical examination, ECG, exer-
cise test and echo).
The acquisition of the data was anonymised and
the investigators had no possibility to draw conclusions
on the identity of a player but only the team he played
for.
The teams were asked to return the question-
naires until the beginning of the tournament. If a team
did not return their questionnaires within four weeks
we sent a reminder.
Results
Participants
The competing 16 national handball teams participated
with a total of 286 players at the 2010 EHF Mens
European Championship. It is important to mention
that the EHF did not impose any speciﬁc warranties
concerning medical screening prior to the
championship.
Finally, 8 of the 16 teams (respectively 122 of a
total of 286 competing players: 42.7%) did return the
Fig. 1: Flow diagram illustrating the modality of cardiovascular pre-partici-
pation screening recommended by the European Society of Cardiology
section of Sports Cardiology (modiﬁed ﬁgure from Corrado et al. [28])
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questionnaires. Although we sent a reminding
invitation to the teams that did not pass their ques-
tionnaires, no further documents have been submitted
subsequently.
Baseline criteria/epidemiologic data
The mean age of the 122 players who returned the
questionnaire was 27.6 years (range 19–38; median:
27.75).
The average duration of physical exercise per
week was 16.7 hours (range 8–28, median: 16.75).
Appropriateness of former cardiac screening
From the eight teams that returned the questionnaire,
four entire teams (labelled in Fig. 2 as 1–4) with a total
of 62 players (50.8% of the players who returned the
questionnaire) were screened correctly according to
the current ESC-/IOC- recommendations. Particularly,
these athletes received an accurate acquisition of the
personal and family history, as well as a focused physi-
cal examination and ﬁnally, a 12-lead resting ECG –
regularly repeated every single or second year.
The four remaining teams were screened inho-
mogeneously: Of their 60 players, only 38 athletes
(31.2% of all submitting players) were screened accord-
ing to the current guidelines, whichmakes a total of 100
athletes of the 122 athletes who have been examined
correctly (82%).
Five players (4.1%) have been screened according
to the current guidelines but not within the last two
years. One athlete (0.8%) received a screening, which
included history and examination but never had an ECG
(this concept complies with the American recommen-
dations; see above). Sixteen players (13.1%) never went
through a speciﬁc screening examination at all.
Initial screening tests
Regarding the very ﬁrst pre-competition screening of
the players, we found that 73 of the athletes whoever got
some kind of screening examination (73/106¼ 69%)
went through their ﬁrst cardiac screening after the age
of 18, while it is recommended to start at an age of 12–14
[9, 15, 18].
Suspicious ﬁndings
By interpreting the questionnaires according to the
recommendations of the ESC/IOC, we identiﬁed 17
athletes (13.9%) with a suspicious personal and/or
family history. Although most of them got unsuspicious
further evaluation (e.g. by stress-test or echocardiogra-
phy), two athletes (1.6%) with a highly suspicious per-
sonal history (shortness of breath out of proportion to
the degree of exertion and exertional chest pain)
belong to the group of players that never underwent
a pre-competition medical screening at all.
Discussion
An accurate medical screening of athletes, espe-
cially if they perform competitive sports implicating a
high impact of physical and psychological stress,
should be a mainstay of every athletes care [15, 16,
18]. Although adequate immediate/emergency care
interventions, e.g. basic life support and the early use
of automatic external deﬁbrillators could potentially
rescue athletes who suffer from sudden cardiac arrest
(SCA), the majority of the events results in serious
outcomes, sometimes even in sudden cardiac death
(SCD) [22–24]. This emphasizes the signiﬁcance of
regular cardiac screening of athletes at any level: More
than an estimated 80% of exercise-related sudden car-
diac deaths can be prevented [7]. The fact that only
50% of the teams in our survey returned the question-
naire may lead to the conclusion that the awareness of
the problem is quite low. Therefore, it is speculative if
the moderate return rate implicates that a cardiac
screening concept of the concerning national teams,
respectively the speciﬁc countries themselves, is lack-
ing. On the other hand, it might point out that a regular
screening program is already well established and thus
the teams did not use the given possibility to participate
in our survey. Nevertheless, the teams that returned the
questionnaire did it in a very accurate way so the data
could be interpreted accurately.
In other surveys, e.g. the evaluation of pre-com-
petition medical assessment (PCMA) prior to the FIFA
Football World Cup 2006, which showed a return-rate
of 82% [21] there was an agreement between the na-
tional associations and the governing body prior to the
survey. This might explain a better compliance.
Fig. 2: Former cardiac screening of the players (122 athletes) who returned
the questionnaire
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One of our major aims was to survey the status
quo of cardiac screening in handball at the European
top level: Therefore, it is important to state that more
than a third of these players (who were screened cor-
rectly) are playing for a national team that integrates
other players which have not been screened according
to the current guidelines. This inhomogeneous pattern
reﬂects the different screening concepts of the coun-
tries these athletes play regularly for their local clubs.
Nevertheless, a governing body as the EHF could pro-
vide guidelines and recommendations to gain an inte-
grative screening concept for its members. Events like
the recent championship can provide further important
information about acceptance and accuracy of the
recommended screening.
Although ﬁve of the participating players (4.1%)
have been screened according to the current guidelines
until 2 years prior to the current championship, they
did not undergo an adequate screening within the last
2 years. As some of the inherited cardiopathies do not
manifest until an older age, screening examinations
should be repeated on a regular basis. Most of the
guidelines recommend the screenings on a 1 or maxi-
mum 2 year basis [6, 18].
One player has been screened regularly according
to the North-American guidelines (only physical exam-
ination and questionnaire). These North-American
guidelines follow a concept, which excludes the 12-lead
resting ECG in the primary screening, mostly due to
reasons of cost-effectiveness and retentions because of
the expected high rate of false-positive ﬁndings. How-
ever, the use of 12-lead resting ECG in the primary
screening leads to a dramatic decrease of exercise-
related sudden cardiac deaths [6–8, 9–12]. The objec-
tion concerning a high rate of false positive ECG
ﬁndings is justiﬁable, but it can be diminished by
improved recommendations concerning the correct
interpretation of an athletes ECG [20]. By analyzing
data from various athletes of different gender, socio-
cultural and ethnic background these recommenda-
tions can be developed further and tailored for a spe-
ciﬁc cohort of athletes [19].
The fact that 16 players (13.1%) at a top level of
one of the most popular sports in Europe never went
through a speciﬁc screening examination at all is alarm-
ing and should have immediate consequences. Only
consistent education may guarantee an adequate
awareness of the problem. Furthermore, due to various
backgrounds of the players, the governing body of the
speciﬁc sport (e.g. the EHF) could provide support by
offering an integrated and comprehensive screening
concept.
The costs of this screening concept are a frequent
detractors target. However, young athletes, in whom a
potentially fatal underlying condition could have been
detected, are likely to survive many decades with a
normal or nearly normal life expectancy [13, 15]. Previ-
ous surveys showed cost estimates per year of life
saved consistently below $ 50,000 [25–27], which is
the traditional threshold to consider a health interven-
tion as cost-effective. A recent analysis estimates that
adding an ECG to history and physical examination in
the screening protocol of athletes aged 14–22 years
saves 2.06 life-years per 1000 athletes, at a cost of
$ 42,000 per life-year saved [27].
Most of the guidelines recommend starting regu-
lar examinations at the very beginning of competitive
sports, which usually equals an age of 12–14 years [6, 9,
11, 12, 15, 18]. Nevertheless, cardiac screening of chil-
dren poses special requirements on the examinator
(e.g. interpretation of ECG). In our survey, 69% of the
athletes whoever got screening examinations went
through their ﬁrst cardiac screening not until the age
of 18, as such far above the recommended level [6, 9, 11,
12, 15, 18].
To gain a rough overview about risk constella-
tions, our questionnaire was supplemented by a section
which included the adapted standardized question-
naire of the screening recommendations of the IOC
(Lausanne recommendations). Interestingly enough,
we identiﬁed 17 athletes (13.9%) with a suspicious
personal and/or family history. Although most of them
got unsuspicious further evaluation (e.g. by stress-test
or echocardiography), 2 athletes (1.6%) with a highly
suspicious personal history belong to the group of
players that never underwent a pre-competition medi-
cal screening at all.
Limitations of the study
Drawbacks that are generated by surveys relying
on questionnaires are obvious: The accuracy of these
self-assessments is unknown and there might be a
trend towards social acceptancewhile answering the
questions. However, this survey should serve as a
position-ﬁxing and should therefore set a founda-
tion stone for a sophisticated screening concept in any
kind of sport.
The moderate return-rate of the questionnaires
may be seen as a drawback. Nevertheless, the percent-
age of participation can also lead to conclusions and the
players who returned the questionnaire did it in a very
accurate way.
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Although we provided the questionnaires in var-
ious languages to increase the approval, there were
still players who had to read questionnaires in a for-
eign language. This might have led to a lower return
rate.
Conclusion
The fact that only 50% of the teams respectively
42.7% of the competing players returned the question-
naire may lead to the conclusion that the awareness of
the problem is quite low.
Most of the national teams showed inhomoge-
neous screening concepts, which may be explained by
different screening concepts of regional clubs these
athletes play for. Apart from the relatively high rate of
82% of players who regularly undergo an adequate
cardiac screening, the fact that 16 players (13.1%) at
this top level never went through a speciﬁc screening
examination at all is alarming and should have imme-
diate consequences, particularly, as two of these players
have a suspicious personal history.
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